Holen Sie sich die Stockscreener-App
672.02
0.17%
-0.97
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$672.99
Offen:
$676.23
24-Stunden-Volumen:
123.73K
Relative Volume:
0.17
Marktkapitalisierung:
$84.34B
Einnahmen:
$344.58B
Nettoeinkommen (Verlust:
$2.83B
KGV:
30.77
EPS:
21.84
Netto-Cashflow:
$1.63B
1W Leistung:
+1.24%
1M Leistung:
+4.93%
6M Leistung:
+34.77%
1J Leistung:
+25.23%
1-Tages-Spanne:
$667.94
$677.73
1-Wochen-Bereich:
$659.48
$678.67
52-Wochen-Spanne:
$464.42
$678.67
Mckesson Corporation Stock (MCK) Company Profile
Firmenname
Mckesson Corporation
Sektor
Branche
Telefon
972-446-4800
Adresse
6555 STATE HIGHWAY 161, IRVING, TX
Vergleichen Sie MCK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MCK
Mckesson Corporation
|
671.82 | 84.34B | 344.58B | 2.83B | 1.63B | 21.84 |
|
COR
Cencora Inc
|
278.28 | 53.87B | 303.19B | 1.40B | -638.10M | 7.03 |
|
CAH
Cardinal Health Inc
|
137.17 | 33.56B | 222.16B | 1.31B | -486.00M | 5.36 |
|
HSIC
Henry Schein Inc
|
69.29 | 8.50B | 12.50B | 314.00M | 421.00M | 2.44 |
|
PDCO
Patterson Companies Inc
|
31.25 | 2.75B | 6.55B | 155.22M | -823.13M | 1.71 |
Mckesson Corporation Stock (MCK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-04 | Fortgesetzt | Mizuho | Neutral |
| 2024-11-07 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-09-24 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-09-05 | Bestätigt | Leerink Partners | Outperform |
| 2024-08-08 | Bestätigt | Mizuho | Neutral |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-12-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-03-31 | Eingeleitet | Citigroup | Buy |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-07-06 | Herabstufung | Argus | Buy → Hold |
| 2022-06-07 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-02-04 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-01-07 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-11-02 | Bestätigt | Barclays | Overweight |
| 2021-11-02 | Bestätigt | BofA Securities | Buy |
| 2021-11-02 | Bestätigt | Evercore ISI | Outperform |
| 2021-11-02 | Bestätigt | Jefferies | Buy |
| 2021-03-30 | Hochstufung | Argus | Hold → Buy |
| 2020-11-02 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-08-04 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-05-22 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-05-15 | Hochstufung | UBS | Neutral → Buy |
| 2020-04-23 | Fortgesetzt | Credit Suisse | Neutral |
| 2020-03-18 | Hochstufung | Goldman | Neutral → Buy |
| 2020-03-13 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-02-07 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-01-10 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-08-05 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2019-07-22 | Eingeleitet | Guggenheim | Neutral |
| 2019-01-17 | Eingeleitet | UBS | Neutral |
| 2018-10-26 | Bestätigt | Barclays | Equal Weight |
| 2018-07-20 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2018-05-29 | Bestätigt | Leerink Partners | Mkt Perform |
| 2018-03-08 | Eingeleitet | Barclays | Equal Weight |
| 2018-02-27 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-02-02 | Bestätigt | Mizuho | Neutral |
| 2018-01-24 | Hochstufung | Jefferies | Hold → Buy |
Alle ansehen
Mckesson Corporation Aktie (MCK) Neueste Nachrichten
McKesson (MCK) Laps the Stock Market: Here's Why - Yahoo Finance
Investing in McKesson (NYSE:MCK) five years ago would have delivered you a 451% gain - Yahoo Finance
McKesson Careers | The future of health starts with you. - McKesson Careers
Is McKesson Corporation (MCK) the Best S&P 500 Stock to Buy for Dividend Growth? - Insider Monkey
McKesson stock soars to all-time high, hits $672 - Investing.com
McKesson stock soars to all-time high, hits $672 By Investing.com - Investing.com South Africa
Wall Street Bulls Look Optimistic About McKesson (MCK): Should You Buy? - Yahoo Finance
Q4 Earnings Outperformers: McKesson (NYSE:MCK) And The Rest Of The Healthcare Providers & Services Stocks - Yahoo Finance
Deutsche Bank Raises Price Target on McKesson to $700 From $663 - MarketScreener
McKesson (MCK): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance
Here is What to Know Beyond Why McKesson Corporation (MCK) is a Trending Stock - Yahoo Finance
With 89% institutional ownership, McKesson Corporation (NYSE:MCK) is a favorite amongst the big guns - Yahoo Finance
McKesson: Immune To Weak Economy And Tariffs; Top Idea In 2025 (NYSE:MCK) - Seeking Alpha
McKesson (MCK) Stock Drops Despite Market Gains: Important Facts to Note - MSN
Trade Tracker: Joe Terranova buys Interactive Brokers and McKesson, sells CVS - CNBC
Is McKesson Corporation (MCK) The Best Healthcare Dividend Stock to Invest in? - Insider Monkey
McKesson (MCK) and Visa (V) Are 2 Dividend Growth Stocks to Buy For a Lifetime of Passive Income - 24/7 Wall St.
McKesson stock soars to all-time high of $667.08 amid robust growth - Investing.com Australia
McKesson stock soars to all-time high of $667.08 amid robust growth By Investing.com - Investing.com South Africa
McKesson (MCK) Increases Yet Falls Behind Market: What Investors Need to Know - Yahoo Finance
McKesson Stock Outshines Alphabet Amid Economic Volatility - Evrim Ağacı
Fortune 50 company puts local facility in midst of closing up for sale - The Business Journals
Telehealth Market Set to Witness Significant Growth by 2025-2032: McKesson Corporation, Cisco Systems, Inc, - EIN News
With 89% ownership of the shares, McKesson Corporation (NYSE:MCK) is heavily dominated by institutional owners - Simply Wall St
American Express Chief Legal Officer earns $11 million compensation in 2024 - ETLegalworld
Wells Fargo Adjusts Price Target on McKesson to $691 From $641, Maintains Equalweight Rating - Marketscreener.com
McKesson Sees Its Composite Rating Rise To 96 - Investor's Business Daily
McKesson (MCK) Advances While Market Declines: Some Information for Investors - Yahoo Finance
McKesson (MCK) Stock Slides as Market Rises: Facts to Know Before You Trade - Yahoo Finance
Is Trending Stock McKesson Corporation (MCK) a Buy Now? - MSN
GS1 US Presents Upcoming Free Webinar: How McKesson and Target Are Electrifying Their Supply Chains Using EPCIS to Share Product Data - Yahoo Finance
McKesson Co. (NYSE:MCK) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World
McKesson Gets IBD Stock Rating Upgrade - Investor's Business Daily
Ambulatory Infusion Center Market Projected To Witness Substantial Growth 2025-2032:McKesson - EIN News
McKesson stock soars to all-time high of $653.97 amid robust growth By Investing.com - Investing.com South Africa
McKesson stock soars to all-time high of $653.97 amid robust growth - Investing.com India
Is McKesson Stock Outperforming the Dow? - Nasdaq
Is McKesson Stock Outperforming The Dow? - Barchart
McKesson Corporation (MCK) Surged on Increased Guidance - MSN
McKesson CEO Tyler Brian S. sells $5.68 million in stock - Investing.com India
Leerink Partners Adjusts Price Target on McKesson to $732 From $690, Keeps Outperform Rating - Marketscreener.com
Finanzdaten der Mckesson Corporation-Aktie (MCK)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.21%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):